mayne and sirtex? Read todays Mayne news from CEO. He is firmly committed to his oncology franchise and will be acquiring growing oncology franchises and companies.Previously I said the most likely acquirers of Sirtex would be Pfizer,Aventis, Bristol Myers, Genentech, Cephalon, or Mayne. After carefully reading todays Mayne news I would believe that Mayne is now the most likely suitor. It would have to beat by alot the previous 2003 Cephalon bid of $4.85, as now Sirtex is highly profitable and growing over 100%+.Read the Mayne news carefully. My opinion after being in the industry along time. Do your own work.
along for the ride?, page-16
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.003(1.64%) |
Mkt cap ! $65.79M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 15.5¢ | $2.784K | 17.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 282041 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 2544375 | 24 |
View Market Depth
| Last trade - 12.23pm 11/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |